Swarajya

Our View
MagazineHeadlinesVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Archives
  • Blogs
  • News Brief

intranasal covid-19 vaccine

Bharat Biotech's Intranasal COVID-19 Vaccine To Cost Rs 800 For Private Markets, Rs 325 For Govt Supplies
Bharat Biotech's Intranasal COVID-19 Vaccine To Cost Rs 800 For Private Markets, Rs 325 For Govt SuppliesPTIDec 27, 2022 02:00 PM +05:30 IST
Centre Signs PPP With Bharat Biotech For Development Plus Commercial Production Of Intranasal Covid-19 And Malaria Vaccines
Centre Signs PPP With Bharat Biotech For Development Plus Commercial Production Of Intranasal Covid-19 And Malaria VaccinesSwarajya StaffMar 27, 2022 01:51 PM +05:30 IST
Vladimir Putin Takes Experimental Intranasal Covid-19 Vaccine Which Russia Is Planning To Export
Vladimir Putin Takes Experimental Intranasal Covid-19 Vaccine Which Russia Is Planning To ExportBhaswati Guha Majumder Nov 25, 2021 03:17 PM +05:30 IST
Bharat Biotech's Covid-19 Nasal Vaccine Shows Promising Results: Centre
Bharat Biotech's Covid-19 Nasal Vaccine Shows Promising Results: CentreBhaswati Guha Majumder Sep 10, 2021 01:52 PM +05:30 IST
Intranasal Covid Vaccines: How They Can Help Fight The Pandemic 
Intranasal Covid Vaccines: How They Can Help Fight The Pandemic Bhaswati Guha Majumder May 4, 2021 01:25 PM +05:30 IST
Indian Drug Regulator's Expert Panel Recommends Phase 1 Trial Of Bharat Biotech's Intranasal Covid-19 Vaccine
Indian Drug Regulator's Expert Panel Recommends Phase 1 Trial Of Bharat Biotech's Intranasal Covid-19 VaccineIANSJan 20, 2021 09:19 AM +05:30 IST
Bharat Biotech To Begin Phase-1 Trials Of Single Dose, Intranasal Covid-19 Vaccine In February-March
Bharat Biotech To Begin Phase-1 Trials Of Single Dose, Intranasal Covid-19 Vaccine In February-MarchSwarajya StaffJan 8, 2021 05:29 PM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype